|
ADDF’s Third Annual
Memories Matter Gala Virtual Event: July 21
WHO: The
Alzheimer's Drug Discovery Foundation (ADDF) presents the Third
Annual Memories Matter Gala through a reimagined virtual
event hosted by Paula Zahn.
Stephanie and Ian Ginsberg, Stephanie is founding
Co-Chair
Wendy Wilshin and Ron Dickerman, Wendy is founding
Co-Chair
Paula Zahn, Host and Executive Producer of Discovery
ID’s “On the Case with Paula Zahn” and WNET’s “NYC Arts.”
(Her mother has Alzheimer’s)
Jay Allen, Country Music Artist (His mother has
Alzheimer’s)
Gina Holzheimer, Co-Chair, ADDF Young Professional
Committee
Josh Lauder, Co-Chair, ADDF Young Professional
Committee (Grandson of Leonard Lauder, Estee Lauder)
Dr. Howard Fillit, Founding Executive Director, Chief
Science Officer, ADDF
WHEN: Tuesday, July 21,
2020, 7:00pm
WHERE: To register for the
free online virtual event, visit https://www.alzdiscovery.org/support-third-annual-memories-matter
ABOUT: The Third Annual
Memories Matter event will feature an interview between
Paula Zahn and the ADDF Chief Science Officer, and a musical
performance by country artist Jay Allen. Every year,
Memories Matter shines a light on the impact Alzheimer’s
has, particularly on younger generations, and shows the
human and emotional aspect of the disease. Several members
of ADDF’s Young Professional’s Committee will share their
personal family connections with Alzheimer’s.
All
proceeds from Memories Matter support the ADDF's mission to
accelerate the discovery and development of drugs to
prevent, treat, and cure Alzheimer's and related diseases.
#
About Alzheimer's Drug Discovery Foundation:
Founded in 1998 by Leonard A. Lauder and Ronald
S. Lauder, the Alzheimer’s Drug Discovery Foundation (ADDF)
is the only philanthropy solely focused on accelerating the
development of drugs to prevent and treat Alzheimer’s
disease. Its venture philanthropy approach and scientific
expertise allows the ADDF to support the most promising
ideas around the world. Our team of expert neuroscientists
find and fund drug discovery projects that have the best
chance of preventing or treating Alzheimer’s and related
dementias. Drug discovery is a chronically underfunded area,
so our investments mean good ideas get explored. And every
idea is a chance at a cure.
|